These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20371488)

  • 21. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
    Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
    Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.
    Zhuang G; Meng C; Guo X; Cheruku PS; Shi L; Xu H; Li H; Wang G; Evans AR; Safe S; Wu C; Zhou B
    Circulation; 2012 Jun; 125(23):2892-903. PubMed ID: 22580331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.
    Kaji H
    Compr Physiol; 2016 Sep; 6(4):1873-1896. PubMed ID: 27783862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immune system's involvement in obesity-driven type 2 diabetes.
    Shu CJ; Benoist C; Mathis D
    Semin Immunol; 2012 Dec; 24(6):436-42. PubMed ID: 23333525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cellular and signaling networks linking the immune system and metabolism in disease.
    Osborn O; Olefsky JM
    Nat Med; 2012 Mar; 18(3):363-74. PubMed ID: 22395709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining macrophage phenotype and function in adipose tissue.
    Dalmas E; Clément K; Guerre-Millo M
    Trends Immunol; 2011 Jul; 32(7):307-14. PubMed ID: 21616718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adipose type I interferon signalling protects against metabolic dysfunction.
    Wieser V; Adolph TE; Grander C; Grabherr F; Enrich B; Moser P; Moschen AR; Kaser S; Tilg H
    Gut; 2018 Jan; 67(1):157-165. PubMed ID: 28011892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Obesity and homeostatic inflammation].
    Ogawa Y
    Nihon Yakurigaku Zasshi; 2011 Nov; 138(5):178-81. PubMed ID: 22075458
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
    Alessi MC; Poggi M; Juhan-Vague I
    Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation and adipose tissue macrophages in lipodystrophic mice.
    Herrero L; Shapiro H; Nayer A; Lee J; Shoelson SE
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):240-5. PubMed ID: 20007767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose Tissue Dendritic Cells: Critical Regulators of Obesity-Induced Inflammation and Insulin Resistance.
    Soedono S; Cho KW
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
    Tam CS; Redman LM
    Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease.
    Chaurasia B; Talbot CL; Summers SA
    Front Immunol; 2020; 11():576347. PubMed ID: 33072120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose inflammation, insulin resistance, and cardiovascular disease.
    Shah A; Mehta N; Reilly MP
    JPEN J Parenter Enteral Nutr; 2008; 32(6):638-44. PubMed ID: 18974244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex immunological and inflammatory network of adipose tissue in obesity.
    Apostolopoulos V; de Courten MP; Stojanovska L; Blatch GL; Tangalakis K; de Courten B
    Mol Nutr Food Res; 2016 Jan; 60(1):43-57. PubMed ID: 26331761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New trends in macrophages, inflammation and adipose tissue].
    Rico-Rosillo MG; Vega-Robledo GB
    Rev Med Inst Mex Seguro Soc; 2012; 50(1):39-45. PubMed ID: 22768816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 production.
    Hoo RL; Chow WS; Yau MH; Xu A; Tso AW; Tse HF; Fong CH; Tam S; Chan L; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2777-82. PubMed ID: 17932317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ron Receptor Tyrosine Kinase Regulates Macrophage Heterogeneity and Plays a Protective Role in Diet-Induced Obesity, Atherosclerosis, and Hepatosteatosis.
    Yu S; Allen JN; Dey A; Zhang L; Balandaram G; Kennett MJ; Xia M; Xiong N; Peters JM; Patterson A; Hankey-Giblin PA
    J Immunol; 2016 Jul; 197(1):256-65. PubMed ID: 27233965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.